Prospective Study Comparing Clinicians’ and Cancer Patients’ Estimates of Risk of Relapse and Toxicity with Adjuvant Chemotherapy
| Autor: | Beatriz Castelo, Jacobo Rogado, Paula Jiménez-Fonseca, Eva Martínez de Castro, Raquel Hernández, Oliver Higuera, Alberto Carmona-Bayonas, Ismael Ghanem, María del Mar Muñoz, Caterina Calderon |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male 0301 basic medicine Oncology Cancer Research medicine.medical_specialty Adjuvant chemotherapy medicine.medical_treatment 03 medical and health sciences 0302 clinical medicine Quality of life Recurrence Risk Factors Neoplasms Physicians Internal medicine medicine Humans Prospective Studies Relapse risk Prospective cohort study Severe toxicity Aged Chemotherapy business.industry Cancer General Medicine Middle Aged medicine.disease Cross-Sectional Studies 030104 developmental biology Chemotherapy Adjuvant 030220 oncology & carcinogenesis Toxicity Female business |
| Zdroj: | Cancer Investigation. 39:589-596 |
| ISSN: | 1532-4192 0735-7907 |
| DOI: | 10.1080/07357907.2021.1948561 |
| Popis: | The aim of this study was to compare physicians' and patients' estimates of risk of relapse and toxicity. A prospective, cross-sectional, multicenter study including 735 patients with cancer and 29 oncologists. Physicians' appraisals of risk of relapse with and without chemotherapy (27.5% and 43.1%) and risk of severe toxicity (12.2%) were more realistic than those of patients (34.6%, 78.5%, and 57.4%, respectively). The greater the risk of recurrence and risk of toxicity estimated, the less physicians expressed satisfaction with SDM. Estimations of risk of relapse and toxicity are important in diagnostic and therapeutic decision-making and can help patients face their situation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|